Validation of a short cognitive battery to screen for fitness-to-drive of people with multiple sclerosis. Akinwuntan, A. E., Backus, D., Grayson, J., & Devos, H. European Journal of Neurology, 25(10):1250–1254, 2018. Number: 10doi abstract bibtex BACKGROUND AND PURPOSE: Some symptoms of multiple sclerosis (MS) affect driving. In a recent study, performance on five cognitive tests predicted the on-road test performance of individuals with relapsing-remitting MS with 91% accuracy, 70% sensitivity and 97% specificity. However, the accuracy with which the battery will predict the driving performance of a different cohort that includes all types of MS is unknown. METHODS: Participants (n = 118; 48 ± 9 years of age; 97 females) performed a comprehensive off-road evaluation that lasted about 3 h and a standardized on-road test that lasted approximately 45 min over a 2-day period within the same week. Performance on the five cognitive tests was used to predict participants' performance on the standardized on-road test. RESULTS: Performance on the five tests together predicted outcome of the on-road test with 82% accuracy, 42% sensitivity and 90% specificity. CONCLUSIONS: The accuracy of predicting the on-road performance of a new MS cohort using performance on the battery of five cognitive tests remained very high (82%). The battery, which was administrable in \textless45 min and cost \textasciitilde\$150, was better at identifying those who actually passed the on-road test (90% specificity). The sensitivity (42%) of the battery indicated that it should not be used as the sole determinant of poor driving-related cognitive skills. A fail performance on the battery should only imply that more comprehensive testing is warranted.
@article{akinwuntan_validation_2018,
title = {Validation of a short cognitive battery to screen for fitness-to-drive of people with multiple sclerosis},
volume = {25},
issn = {1468-1331},
doi = {10.1111/ene.13690},
abstract = {BACKGROUND AND PURPOSE: Some symptoms of multiple sclerosis (MS) affect driving. In a recent study, performance on five cognitive tests predicted the on-road test performance of individuals with relapsing-remitting MS with 91\% accuracy, 70\% sensitivity and 97\% specificity. However, the accuracy with which the battery will predict the driving performance of a different cohort that includes all types of MS is unknown.
METHODS: Participants (n = 118; 48 ± 9 years of age; 97 females) performed a comprehensive off-road evaluation that lasted about 3 h and a standardized on-road test that lasted approximately 45 min over a 2-day period within the same week. Performance on the five cognitive tests was used to predict participants' performance on the standardized on-road test.
RESULTS: Performance on the five tests together predicted outcome of the on-road test with 82\% accuracy, 42\% sensitivity and 90\% specificity.
CONCLUSIONS: The accuracy of predicting the on-road performance of a new MS cohort using performance on the battery of five cognitive tests remained very high (82\%). The battery, which was administrable in {\textless}45 min and cost {\textasciitilde}\$150, was better at identifying those who actually passed the on-road test (90\% specificity). The sensitivity (42\%) of the battery indicated that it should not be used as the sole determinant of poor driving-related cognitive skills. A fail performance on the battery should only imply that more comprehensive testing is warranted.},
language = {eng},
number = {10},
journal = {European Journal of Neurology},
author = {Akinwuntan, A. E. and Backus, D. and Grayson, J. and Devos, H.},
year = {2018},
pmid = {29802779},
note = {Number: 10},
keywords = {Adult, Automobile Driver Examination, Automobile Driving, Cognition, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Neuropsychological Tests, Sensitivity and Specificity, cognition, driving, evaluation, multiple sclerosis, vision},
pages = {1250--1254},
}
Downloads: 0
{"_id":"cJnmtbpFu6k2hSD4Q","bibbaseid":"akinwuntan-backus-grayson-devos-validationofashortcognitivebatterytoscreenforfitnesstodriveofpeoplewithmultiplesclerosis-2018","author_short":["Akinwuntan, A. E.","Backus, D.","Grayson, J.","Devos, H."],"bibdata":{"bibtype":"article","type":"article","title":"Validation of a short cognitive battery to screen for fitness-to-drive of people with multiple sclerosis","volume":"25","issn":"1468-1331","doi":"10.1111/ene.13690","abstract":"BACKGROUND AND PURPOSE: Some symptoms of multiple sclerosis (MS) affect driving. In a recent study, performance on five cognitive tests predicted the on-road test performance of individuals with relapsing-remitting MS with 91% accuracy, 70% sensitivity and 97% specificity. However, the accuracy with which the battery will predict the driving performance of a different cohort that includes all types of MS is unknown. METHODS: Participants (n = 118; 48 ± 9 years of age; 97 females) performed a comprehensive off-road evaluation that lasted about 3 h and a standardized on-road test that lasted approximately 45 min over a 2-day period within the same week. Performance on the five cognitive tests was used to predict participants' performance on the standardized on-road test. RESULTS: Performance on the five tests together predicted outcome of the on-road test with 82% accuracy, 42% sensitivity and 90% specificity. CONCLUSIONS: The accuracy of predicting the on-road performance of a new MS cohort using performance on the battery of five cognitive tests remained very high (82%). The battery, which was administrable in \\textless45 min and cost \\textasciitilde\\$150, was better at identifying those who actually passed the on-road test (90% specificity). The sensitivity (42%) of the battery indicated that it should not be used as the sole determinant of poor driving-related cognitive skills. A fail performance on the battery should only imply that more comprehensive testing is warranted.","language":"eng","number":"10","journal":"European Journal of Neurology","author":[{"propositions":[],"lastnames":["Akinwuntan"],"firstnames":["A.","E."],"suffixes":[]},{"propositions":[],"lastnames":["Backus"],"firstnames":["D."],"suffixes":[]},{"propositions":[],"lastnames":["Grayson"],"firstnames":["J."],"suffixes":[]},{"propositions":[],"lastnames":["Devos"],"firstnames":["H."],"suffixes":[]}],"year":"2018","pmid":"29802779","note":"Number: 10","keywords":"Adult, Automobile Driver Examination, Automobile Driving, Cognition, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Neuropsychological Tests, Sensitivity and Specificity, cognition, driving, evaluation, multiple sclerosis, vision","pages":"1250–1254","bibtex":"@article{akinwuntan_validation_2018,\n\ttitle = {Validation of a short cognitive battery to screen for fitness-to-drive of people with multiple sclerosis},\n\tvolume = {25},\n\tissn = {1468-1331},\n\tdoi = {10.1111/ene.13690},\n\tabstract = {BACKGROUND AND PURPOSE: Some symptoms of multiple sclerosis (MS) affect driving. In a recent study, performance on five cognitive tests predicted the on-road test performance of individuals with relapsing-remitting MS with 91\\% accuracy, 70\\% sensitivity and 97\\% specificity. However, the accuracy with which the battery will predict the driving performance of a different cohort that includes all types of MS is unknown.\nMETHODS: Participants (n = 118; 48 ± 9 years of age; 97 females) performed a comprehensive off-road evaluation that lasted about 3 h and a standardized on-road test that lasted approximately 45 min over a 2-day period within the same week. Performance on the five cognitive tests was used to predict participants' performance on the standardized on-road test.\nRESULTS: Performance on the five tests together predicted outcome of the on-road test with 82\\% accuracy, 42\\% sensitivity and 90\\% specificity.\nCONCLUSIONS: The accuracy of predicting the on-road performance of a new MS cohort using performance on the battery of five cognitive tests remained very high (82\\%). The battery, which was administrable in {\\textless}45 min and cost {\\textasciitilde}\\$150, was better at identifying those who actually passed the on-road test (90\\% specificity). The sensitivity (42\\%) of the battery indicated that it should not be used as the sole determinant of poor driving-related cognitive skills. A fail performance on the battery should only imply that more comprehensive testing is warranted.},\n\tlanguage = {eng},\n\tnumber = {10},\n\tjournal = {European Journal of Neurology},\n\tauthor = {Akinwuntan, A. E. and Backus, D. and Grayson, J. and Devos, H.},\n\tyear = {2018},\n\tpmid = {29802779},\n\tnote = {Number: 10},\n\tkeywords = {Adult, Automobile Driver Examination, Automobile Driving, Cognition, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Neuropsychological Tests, Sensitivity and Specificity, cognition, driving, evaluation, multiple sclerosis, vision},\n\tpages = {1250--1254},\n}\n\n","author_short":["Akinwuntan, A. E.","Backus, D.","Grayson, J.","Devos, H."],"key":"akinwuntan_validation_2018","id":"akinwuntan_validation_2018","bibbaseid":"akinwuntan-backus-grayson-devos-validationofashortcognitivebatterytoscreenforfitnesstodriveofpeoplewithmultiplesclerosis-2018","role":"author","urls":{},"keyword":["Adult","Automobile Driver Examination","Automobile Driving","Cognition","Female","Humans","Male","Middle Aged","Multiple Sclerosis","Neuropsychological Tests","Sensitivity and Specificity","cognition","driving","evaluation","multiple sclerosis","vision"],"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/NLRC_ShepherdCenter","dataSources":["CsrWgc2HAR4m2Agiw"],"keywords":["adult","automobile driver examination","automobile driving","cognition","female","humans","male","middle aged","multiple sclerosis","neuropsychological tests","sensitivity and specificity","cognition","driving","evaluation","multiple sclerosis","vision"],"search_terms":["validation","short","cognitive","battery","screen","fitness","drive","people","multiple","sclerosis","akinwuntan","backus","grayson","devos"],"title":"Validation of a short cognitive battery to screen for fitness-to-drive of people with multiple sclerosis","year":2018}